Keyword search (4,164 papers available)

"Resting state" Keyword-tagged Publications:

Title Authors PubMed ID
1 Effect of a single dose of lorazepam on resting state functional connectivity in healthy adults Ferland MC; Wang R; Therrien-Blanchet JM; Remahi S; Côté S; Fréchette AJ; Dang-Vu TT; Liu H; Lepage JF; Théoret H; 40646404
PERFORM
2 Sex-specific effects of intensity and dose of physical activity on BOLD-fMRI cerebrovascular reactivity and cerebral pulsatility Potvin-Jutras Z; Intzandt B; Mohammadi H; Liu P; Chen JJ; Gauthier CJ; 40079560
SOH
3 Human Auditory-Motor Networks Show Frequency-Specific Phase-Based Coupling in Resting-State MEG Bedford O; Noly-Gandon A; Ara A; Wiesman AI; Albouy P; Baillet S; Penhune V; Zatorre RJ; 39757971
PSYCHOLOGY
4 Neural correlates of impulsivity in amphetamine use disorder Kaboodvand N; Shabanpour M; Guterstam J; 38991286
ENCS
5 Validating MEG source imaging of resting state oscillatory patterns with an intracranial EEG atlas Afnan J; von Ellenrieder N; Lina JM; Pellegrino G; Arcara G; Cai Z; Hedrich T; Abdallah C; Khajehpour H; Frauscher B; Gotman J; Grova C; 37149236
PERFORM
6 Detection of abnormal resting-state networks in individual patients suffering from focal epilepsy: an initial step toward individual connectivity assessment. Dansereau CL, Bellec P, Lee K, Pittau F, Gotman J, Grova C 25565949
PERFORM
7 Disruption, emergence and lateralization of brain network hubs in mesial temporal lobe epilepsy. Lee K, Khoo HM, Lina JM, Dubeau F, Gotman J, Grova C 30094158
PERFORM
8 Biomarkers, designs, and interpretations of resting-state fMRI in translational pharmacological research: A review of state-of-the-Art, challenges, and opportunities for studying brain chemistry. Khalili-Mahani N, Rombouts SA, van Osch MJ, Duff EP, Carbonell F, Nickerson LD, Becerra L, Dahan A, Evans AC, Soucy JP, Wise R, Zijdenbos AP, van Gerven JM 28145075
PERFORM

 

Title:Effect of a single dose of lorazepam on resting state functional connectivity in healthy adults
Authors:Ferland MCWang RTherrien-Blanchet JMRemahi SCôté SFréchette AJDang-Vu TTLiu HLepage JFThéoret H
Link:https://pubmed.ncbi.nlm.nih.gov/40646404/
DOI:10.1007/s11682-025-01043-4
Publication:Brain imaging and behavior
Keywords:BenzodiazepineFunctional connectivityLorazepamResting statefMRI
PMID:40646404 Category: Date Added:2025-07-12
Dept Affiliation: PERFORM
1 Department of Psychology, Faculté des Arts et Sciences, Université de Montréal, Montréal, Canada.
2 Changping Laboratory & Peking University, Beijing, China.
3 Department of Pediatrics, Faculty of Medicine and Health Sciences, Université Sherbrooke Hospital Research Center, Sherbrooke, Canada.
4 Center for Studies in Behavioral Neurobiology and Perform Center, Department of Health, Kinesiology and Applied Physiology, Concordia University, Montréal, Canada.
5 Research Center, Institut Universitaire de Gériatrie de Montréal, Montréal, Canada.
6 Department of Psychology, Faculté des Arts et Sciences, Université de Montréal, Montréal, Canada. hugo.theoret@umontreal.ca.

Description:

Lorazepam is a fast-acting benzodiazepine that is widely used to manage anxiety symptoms through modulation of GABAergic activity. Despite being one of the most prescribed benzodiazepines, the effects of a single dose of lorazepam on brain functional connectivity at rest is not known. In this placebo-controlled, crossover study, twenty healthy adult participants (9 women; 26.2 ± 5.2 years) underwent two resting-state fMRI (rs-fMRI) scans following administration of either lorazepam (2.5 mg) or placebo. Imaging data were analyzed using an individual brain network parcellation approach and differences in functional connectivity among 78 individual-specific ROIs were estimated. Compared to placebo, functional connectivity was reduced following administration of lorazepam between the left medial paracentral lobule and left temporal pole and between the left posterior cingulate sulcus and right cuneus. Reduced connectivity within higher-order cognitive networks partly supports what has been reported for other benzodiazepines such as midazolam and alprazolam. However, differences across benzodiazepines - possibly due to pharmacokinetics, dosage and receptor selectivity - underscore the need for further research.





BookR developed by Sriram Narayanan
for the Concordia University School of Health
Copyright © 2011-2026
Cookie settings
Concordia University